Open Access

A new era for Inflammation and Regeneration

Inflammation and Regeneration201636:3

https://doi.org/10.1186/s41232-016-0003-8

Received: 15 March 2016

Accepted: 2 April 2016

Published: 25 April 2016

It is my great pleasure to announce the launch of new alliance between our journal, Inflammation and Regeneration, and an international publisher, BioMed Central. Inflammation and Regeneration is the official journal of the Japanese Society of Inflammation and Regeneration. Inflammation and Regeneration provides a forum which covers a wide range of scientific topics in the research field of inflammation and basic and clinical regenerative medicine, such as basic biology of somatic stem cells [1], pluripotency [2], direct reprogramming [3], cell therapy using iPS cell technology [4], disease modeling with iPS cell technology [5], immunoregulation by mesenchymal stromal cells [6], immunoregulation in regenerative medicine [7], tissue homeostasis in health and disease [8], tissue engineering [9], interaction between gut microbiota and host immune cells [10], dendritic cells [11], vascular biology [12], cancer immunology [13], regulatory T cells and immunomodulation [14], intestinal immunity and inflammation [15], inflammation and oxidative stress [16], cellular and molecular bases for fibrotic diseases [17], and new therapeutics of autoimmune disorders [18]. As are the cases for these topics, inflammation research and regenerative medicine are tightly linked research areas in life sciences and their significance in translational research is rapidly increasing. To promote globalization of the journal, inclusion within PubMed Central, and early acquisition of an impact factor, we have decided to strengthen the organization of the journal by establishing this alliance with an international, reliable publisher. Dedicated to open research, BioMed Central publishes a large portfolio of peer-reviewed, open access journals in biology, clinical medicine, and health. From now on, I, as the Editor-in-Chief, encourage the submission of manuscripts whose scope bridges the fields of inflammation and regeneration.

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Physiology, Keio University School of Medicine

References

  1. Iwama A. Recent advances in stem cell biology in regeneration and disease. Inflammation and Regeneration. 2013;33:173–4.View ArticleGoogle Scholar
  2. Okita K, Yamanaka S. Recent advance in induced pluripotent stem cells. Inflammation and Regeneration. 2008;31:361–4.Google Scholar
  3. Suzuki A. Direct reprogramming. Inflammation and Regeneration. 2014;34:209–10.View ArticleGoogle Scholar
  4. Kuwabara T, Asashima M. Prospects for regeneration therapy with stem cells. Inflammation and Regeneration. 2012;32:8–15.View ArticleGoogle Scholar
  5. Saito MK, Niwa A. Disease-associated iPS cell lines representing hematological and immunological disorders. Inflammation and Regeneration. 2012;32:171–7.View ArticleGoogle Scholar
  6. Payne Natalie L, Bernard CC. Mesenchymal stem cells and immunomodulation. Inflammation and Regeneration. 2014;34:165–7.View ArticleGoogle Scholar
  7. Wada H, Kudo H, Sasaki H, Baghdadi M, Seino K-i. New immune regulation strategy in the age of regenerative medicine using pluripotent stem cells. Inflammation and Regeneration. 2015;35:238–43.View ArticleGoogle Scholar
  8. Oike Y. Cutting-edge research exploring mechanisms of tissue homeostasis in health and disease. Inflammation and Regeneration. 2015;35:164–6.View ArticleGoogle Scholar
  9. Tabata Y. Positioning of tissue engineering in regenerative medicine. Inflammation and Regeneration. 2014;34:1–3.View ArticleGoogle Scholar
  10. Yoshimura A. Interaction between gut microbiota and host immune cells. Inflammation and Regeneration. 2015;35:97–8.View ArticleGoogle Scholar
  11. Miyamoto T, Toyama Y. DC-STAMP and osteoimmunology. Inflammation and Regeneration. 2009;29:59–62.View ArticleGoogle Scholar
  12. Murakami M, Shibuya M. Involvement of vascular endothelial growth factorreceptor-1 in rheumatoid arthritis. Inflammation and Regeneration. 2008;28:78–85.View ArticleGoogle Scholar
  13. Kawamoto H. Immunoregulation in regenerative medicine. Inflammation and Regeneration. 2015;35:218–9.View ArticleGoogle Scholar
  14. Kawahata K, Kanzaki T, Imamura M, Akahira L, Michishita K, Dohi M, et al. Regulatory T cells in the control of T cell homeostasis. Inflammation and Regeneration. 2010;30:502–6.View ArticleGoogle Scholar
  15. Takeda K. Cutting-edge research on intestinal immunity and inflammation. Inflammation and Regeneration. 2015;35:1–2.View ArticleGoogle Scholar
  16. Dogru M, Matsumoto Y, Tsubota K. The role of oxidative stress and inflammation inthe pathogenesis of dry eye. Inflammation and Regeneration. 2007;27:559–64.View ArticleGoogle Scholar
  17. Sakai N, Wada T, Matsushima K, Kaneko S. The role of fibrocytes in progressive renal fibrosis. Inflammation and Regeneration. 2007;27:494–8.View ArticleGoogle Scholar
  18. Tanaka T, Narazaki M, Masuda K, Kishimoto T. Interleukin-6; pathogenesis and treatment of autoimmune inflammatory diseases. Inflammation and Regeneration. 2013;33:54–65.View ArticleGoogle Scholar

Copyright

© Okano 2016

Advertisement